Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
04/24SMITH & NEPHEW : Wound Care Products Market Analysis, Trends and Forecast by 2025
AQ
04/24ANTHEM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
04/24NEPRILYSIN MARKET INSIGHT, TRENDS AND ANALYSIS BY 2025 : Worldwide Neprilysin 2019 Research Report presents a professional and complete analysis of Global Neprilysin Market on the current situation.
AQ
04/24IDEXX LABORATORIES : Two Portland-area veterinary companies settle lawsuit
AQ
04/24PIXIUM VISION : announces change in Governance
AQ
04/24HEXO : increases lock-up agreements to over 38% of Newstrike shareholders
AQ
04/24ESSILORLUXOTTICA : Board of Directors voted against the proposed complementary resolutions submitted by shareholders for inclusion on the agenda of the May 16, 2019 General Meeting
PU
04/24Key Healthcare Stocks To Watch as US Markets Approach Record Highs
AQ
04/24STRYKER : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
04/24ROCHE : Breast cancer drug 'undecided'
AQ
04/24ROCHE : Pharmac says it is yet to decide over paying for in-demand meds
AQ
04/24GHP SPECIALTY CARE PUBL : Communiqué from GHP's Annual General Meeting 2019
AQ
04/24BAVARIAN NORDIC A/S : – Report on the Results of the Annual General Meeting, held April 24, 2019
AQ
04/24BIOHIT OYJ : Decisions of the Annual General Meeting of Biohit Oyj
AQ
04/24BASILEA PHARMACEUTICA : Forge And Basilea Enter Into Multi-Target Agreement To Discover And Develop Novel Antibiotics
PR
Discover
04/24MALLINCKRODT : Completes Expansion of Operations and Manufacturing Facility for StrataGraft® Regenerative Skin Tissue in Madison, Wis.
PR
04/24ADVERUM BIOTECHNOLOGIES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
04/24VARIAN MEDICAL SYSTEMS INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
04/24RESEARCHERS SUBMIT PATENT APPLICATION, “TOPICAL SPRAY FORMULATION OF GLYCOPYRROLATE”, FOR APPROVAL (USPTO 20190099344) : Suven Life Sciences Limited
AQ
04/24HCA HEALTHCARE, INC. : to Present at May Healthcare Conferences
BU
04/24OMNICELL : The University of Tennessee Medical Center Selects Omnicell Solutions to Support Medication Management Strategy
PR
04/24FLEXION THERAPEUTICS : Announces Publication of Analysis of Patients with Unilateral Knee OA from Pivotal Trial of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
AQ
04/24VANDA PHARMACEUTICALS : Appoints Phaedra Chrousos to Board of Directors
PR
04/24MILLENDO THERAPEUTICS : Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BU
04/24ELECTROMED, INC. : Schedules Release of Third Quarter Fiscal 2019 Financial Results and Conference Call
BU
04/24BeyondSpring to Host Fourth-Quarter and Full-Year 2018 Financial Results and Operational Update Conference Call on April 30, 2019
GL
04/24MacroGenics Announces Date of First Quarter 2019 Financial Results Conference Call
GL
04/24CATASYS APPOINTS HEALTHCARE INDUSTRY LEADER CAROL MURDOCK TO NEWLY CREATED CHIEF COMMERCIAL OFFICER ROLE : Catasys Inc.
AQ
04/24JAPAN - PATENT ISSUED FOR MEDICAL INSTRUMENT, MEDICAL SYSTEM, AND MODE TRANSITION METHOD FOR MEDICAL INSTRUMENTS (USPTO 10,251,536) : Olympus Corporation
AQ
04/24“METHOD FOR SYNTHESIZING ETELCALCETIDE OR SALTS THEREOF” IN PATENT APPLICATION APPROVAL PROCESS (USPTO 20190100554) : Chunghwa Chemical Synthesis & Biotech Co. Ltd.
AQ
04/24RESEARCHERS SUBMIT PATENT APPLICATION, “TREATMENT FOR LIPODYSTROPHY”, FOR APPROVAL (USPTO 20190100492) : Cadila Healthcare Limited
AQ
04/24CONFORMIS INC : Change in Directors or Principal Officers (form 8-K)
AQ
04/24SUNNIVA : Announces Closing Of Second Tranche Of Short-Term Bridge Financing For Proceeds Of CAD $1,210,000
AQ
04/24Supernus to Host First Quarter 2019 Earnings Conference Call
GL
04/24LeMaitre Vascular Will Announce First Quarter 2019 Earnings Results on May 1, 2019
GL
04/24CLOVIS ONCOLOGY : Download PDF format download (opens in new window)
PU
04/24FLUIDIGM CORP : Change in Directors or Principal Officers (form 8-K)
AQ
04/24THERAPEUTICSMD : Closes $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners
BU
04/24VARIAN : Reports Results for Second Quarter of Fiscal Year 2019
PR
04/24AURINIA PHARMACEUTICALS : to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
BU
04/24REVANCE THERAPEUTICS : to Release First Quarter 2019 Financial Results on Wednesday, May 8, 2019
BU
04/24SI BONE : To Report First Quarter 2019 Financial Results on May 8, 2019
AQ
04/24Quotient Limited Announces Initial SDS EU Field Trial Performance Data for MosaiQ™
GL
04/24Evolus to Release First Quarter 2019 Financial Results and Provide a Business Update on Tuesday, April 30, 2019
GL
04/24CLOVIS ONCOLOGY : to Announce First Quarter 2019 Financial Results and Host Webcast Conference Call on May 7
BU
04/24VAXART, INC. : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
04/24PLANET 13 : dispensary expansion project set for completion this year
AQ
04/24ALKERMES : Appoints Industry Veteran C. Todd Nichols as Senior Vice President of Sales and Marketing
PR
04/24Collegium to Host Conference Call to Discuss First Quarter 2019 Financial Results and Provide Corporate Update
GL
04/24Xenon Pharmaceuticals to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
GL
04/24CONMED CORPORATION : Announces First Quarter 2019 Financial Results
BU
04/24Adverum Biotechnologies Appoints Thomas Leung as Chief Financial Officer
GL
04/24Align Technology Announces First Quarter 2019 Financial Results
GL
04/24ARROWHEAD PHARMACEUTICALS : to Webcast Fiscal 2019 Second Quarter Results
BU
04/24DEXCOM INC : Change in Directors or Principal Officers (form 8-K)
AQ
04/24COLLPLANT : Announces Publication of Study in Science Translational Medicine Showing Composite Matrix Based on rhCollagen, Ceramics and Bone Morphogenic Protein Led to Bone Growth Superior to Standard of Care
PU
04/24EASTON PHARMACEUTICALS : Closes Purchase of Food Processing Company Specializing in Baked Goods with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market
AQ
04/24TAURINE MARKET INVESTMENT OPPORTUNITIES AND FORECAST 2019-2025 : The Taurine Market Research report provides deep information of Size, Share, Leaders, Company Profiles, Industry Trends and Demand
AQ
04/24AZURRX BIOPHARMA, INC. : Other Events (form 8-K)
AQ
04/24LEXINGTON BIOSCIENCES : IIROC Trading Halt - LNB
AQ
04/24NATURAL ALTERNATIVES INTERNATIONAL : Beta-Alanine for Food Application Receives Approval from Japanese Ministry of Health, Labor and Welfare
PR
04/24CRH MEDICAL CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
04/24SUNNIVA INC : . Announces Collaborative Relationship Between Natural Health Services And UNIFOR To Provide Cannabis Education Services To UNIFOR Members
AQ
04/24THE FLOWR CORPORATION (TSX.V : FLWR) (OTC: FLWPF) Registers First Sales of Premium Cannabis, Cultivation Facility on Pace for Q3 2019 Completion
AQ
04/24INTEGER HOLDINGS CORPORATION (NYSE : ITGR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
AQ
Discover
04/24ASSERTIO THERAPEUTICS : to Report First Quarter 2019 Financial Results After The Close of Markets on Wednesday, May 8, 2019
AQ
04/24PATENT APPLICATION TITLED “CANNABINOID EXTRACTION PROCESS USING BRINE” PUBLISHED ONLINE (USPTO 20190099696) : NextLeaf Solutions Ltd.
AQ
04/24PERKINELMER INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
04/24ADVERUM BIOTECHNOLOGIES, INC. (NASDAQ : ADVM) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
AQ
04/24INTEGRATED CANNABIS : Announces $5,000,000 Non-Brokered Private Placement
AQ
Prev.1  2  3  4  5   6  7  8  9  10Next
Advertisement